🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Status
Unknown
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2019-02-15
Trial ID
NCT03487016
Treatments Being Tested
To evaluate the efficacy and safety of totally neoadjuvant FOLFOXIRI chemot...
Status
Unknown
Location
China Medical University
Start Date
2018-04-01
Trial ID
NCT03484221
Treatments Being Tested
The primary objectives of this control, single-center clinical study of End...
Status
Unknown
Location
Cancer Hospital of Xinjiang Medical University
Start Date
2013-08
Trial ID
NCT02008422
Treatments Being Tested
This study is to assess the efficacy and safety of Endostar combined with m...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2013-01
Trial ID
NCT01832948
Treatments Being Tested
Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2015-05
Trial ID
NCT02359162
The purpose of this study is to see if there is a difference in survival be...
Status
Completed
Location
Akademiska Sjukhuset (Uppsala University Hospital)
Start Date
2003-06
Trial ID
NCT01524094
While the association of physical and/or motor and/or cognitive components ...
Status
Completed
Location
Club seniors Kennedy
Start Date
2023-02-13
Trial ID
NCT05991011
This is an open-label, randomized, controlled, multicenter, phase III study...
Status
Not Yet Recruiting
Location
Charité Universitätsmedizin Berlin
Start Date
2025-04
Trial ID
NCT06899477
Treatments Being Tested